Harm Reduction Therapeutics In The News The latest stories and news about Harm Reduction Therapeutics, OTC RiVive®, and naloxone Sep 3, 2024 Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive® Life-Saving Over-the-Counter Naloxone Nasal SprayRead More Aug 27, 2024 Compassionate Overdose Response Summit Highlights and Key TakeawaysRead More Aug 14, 2024 A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and VeteransRead More Jul 29, 2024 Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal FormulationsRead More Jul 22, 2024 Exploring Cost and the Emerging Landscape of Naloxone CompetitionRead More Mar 1, 2024 Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™Read More Bystander Naloxone Administration: Amounts and Dosages versus EMS Naloxone Administration Feb 3, 2024 First Shipment of RiVive™ Brings Life-Saving Over-The-Counter Naloxone Nasal Spray One Step Closer to Those Who Need It Most Dec 18, 2023 Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis Dec 12, 2023 Narcan Now Available Over-the-counter – What to Know Sep 5, 2023 Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution Aug 17, 2023 A new, cheaper naloxone is coming to pharmacy shelves, funded in part by Purdue Pharma’s bankruptcy Aug 17, 2023 FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE Aug 1, 2023 Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose Apr 11, 2023 Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray Mar 24, 2023 Load More Load More
Sep 3, 2024 Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive® Life-Saving Over-the-Counter Naloxone Nasal SprayRead More
Aug 14, 2024 A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and VeteransRead More
Jul 29, 2024 Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal FormulationsRead More
Mar 1, 2024 Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™Read More